Valuation Formosa Laboratories, Inc.

Stocks

End-of-day quote Taiwan S.E. Other stock markets 22/07/2026			5-day change	1st Jan Change
52.10 ^TWD	0.00%		-3.34%	-12.14%

05-14	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-17	Formosa Laboratories, Inc. Receives US FDA Approval For Eribulin Injection Under ANDA Pathway	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	5,085	7,275	8,839	12,266	8,274	7,131
Change	-	43.07%	21.49%	38.78%	-32.55%	-13.81%
Enterprise Value (EV) ¹	8,446	9,602	11,008	13,819	9,470	8,247
Change	-	13.69%	14.64%	25.53%	-31.47%	-12.91%
P/E	13.6x	5.86x	21.7x	97.2x	52.9x	16.3x
PBR	0.98x	0.98x	1.18x	1.62x	1.08x	0.92x
PEG	-	0x	-0.3x	-1.4x	2.2x	0x
Capitalization / Revenue	1.65x	2.32x	2.35x	2.81x	1.75x	1.47x
EV / Revenue	2.75x	3.06x	2.92x	3.17x	2x	1.7x
EV / EBITDA	18.1x	32.4x	17.6x	12.3x	7.73x	6.14x
EV / EBIT	302x	-57.2x	67.3x	20.5x	13x	10.3x
EV / FCF	-11.8x	-56.1x	47x	37.1x	-128x	20x
FCF Yield	-8.46%	-1.78%	2.13%	2.69%	-0.78%	4.99%
Dividend per Share ²	-	2	1	2	3	3
Rate of return	-	3.31%	1.36%	1.96%	4.36%	5.06%
EPS ²	3.459	10.32	3.39	1.05	1.3	3.64
Distribution rate	-	19.4%	29.5%	191%	231%	82.4%
Net sales ¹	3,075	3,142	3,766	4,360	4,731	4,851
EBITDA ¹	467.6	296.6	623.8	1,127	1,225	1,344
EBIT ¹	28.01	-168	163.5	675	725.9	803.2
Net income ¹	400	1,249	409.4	126.2	157.3	441.1
Net Debt ¹	3,361	2,327	2,169	1,553	1,196	1,115
Reference price ²	46.95	60.50	73.50	102.00	68.80	59.30
Nbr of stocks (in thousands)	108,313	120,256	120,256	120,256	120,256	120,256
Announcement Date	3/8/21 A	3/11/22 A	3/15/23 A	3/12/24 A	3/13/25 A	3/13/26 A

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FORMOSA LABORATORIES, INC.	-	-	-	-	193M
ELI LILLY AND COMPANY	34.57x	12.36x	25.86x	0.58%	1,037B
JOHNSON & JOHNSON	27.4x	6.26x	17.33x	2.1%	615B
ABBVIE INC.	33x	7.49x	15.4x	2.71%	448B
ROCHE HOLDING AG	17.76x	4.4x	10.85x	3.01%	326B
NOVARTIS AG	21.11x	5.63x	13.79x	2.84%	293B
ASTRAZENECA PLC	21.21x	4.47x	12.37x	1.97%	264B
NOVO NORDISK A/S	14.09x	5.24x	10.8x	3.55%	216B
AMGEN INC.	24.01x	6.34x	11.18x	2.76%	198B
GILEAD SCIENCES, INC.	-46.95x	5.62x	31.09x	2.53%	162B
Average	16.24x	6.43x	16.52x	2.45%	355.76B
Weighted average by Cap.	23.96x	7.75x	18.21x	2.01%